REFERENCES

1. Bazarian JJ, Biberthaler P, Welch RD, et al. Serum GFAP and UCH-L1 for prediction of absence of intracranial injuries on head CT (ALERT-TBI): a multicentre observational study. Lancet Neurol. 2018;17(9): 782-789. https://doi.org/10.1016/s1474-4422(18)30231-x.
2. Bazarian JJ, Welch RD, Caudle K, et al. Accuracy of a rapid glial fibrillary acidic protein/ubiquitin carboxyl-terminal hydrolase L1 test for the prediction of intracranial injuries on head computed tomography after mild traumatic brain injury. Acad Emerg Med. 2021 Nov;28(11):1308-1317. doi: 10.1111/acem.14366. Epub 2021 Sep 7.
3. Abbott Point of Care Inc., 2021, 510(k) Summary: i-STAT TBI Plasma Cartridge with the i-STAT Alinity System (K201778; Approved 8JAN2021); 2021. https://www.accessdata.fda.gov/cdrh_docs/pdf20/K201778.pdf . Accessed 16 February 2021.
4. Abbott Point of Care, Inc., 2024, 510(k) Summary: i-STAT TBI cartridge with the i-STAT Alinity System (K234143; Approved 27MAR2024). https://www.accessdata.fda.gov/cdrh_docs/reviews/K234143.pdf . Accessed 19 Aug 2024.
5. Yue JK, Yuh EL, Korley FK, et al. Association between plasma GFAP concentrations and MRI abnormalities in patients with CT-negative traumatic brain injury in the TRACK-TBI cohort: a prospective multicentre study. Lancet Neurol. 2019;18(10): 953-961. https://doi.org/10.1016/s1474-4422(19)30282-0 .